As signaling molecules, SCFAs exert anti-obesity effects by activating PPAR-γ in the liver and WAT and G protein-coupled receptors GPR43/FFAR2 and GPR41/FFAR3 [99]. Here, FFAR2 is linked to obesity disorder.